Scisparc

Scisparc Total Assets

The Total Assets of Scisparc (SPRC) as of Oct 16, 2026 is 7.62 M USD. In the previous year, Total Assets was 10.35 M USD — a change of -26.34% (lower).

Total Assets

7.62 MUSD

YoY

-26.34%

Last updated:

Total Assets of Scisparc is 2025 7.62 M USD. Total Assets of Scisparc was 2024 10.35 M USD. It decreases by -26.34% lower compared to the previous year.

The Scisparc Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2018
4.56 M USD
Jan 1, 2019
1.15 M USD
Jan 1, 2020
2.56 M USD
Jan 1, 2021
9.92 M USD
Jan 1, 2022
10.61 M USD
Jan 1, 2023
11.18 M USD
Jan 1, 2024
10.35 M USD
Jan 1, 2025
7.62 M USD
The Scisparc Total Assets history
YEARTotal AssetsYoY
7.62 MUSD-26.34%
10.35 MUSD-7.47%
11.18 MUSD+5.44%
10.61 MUSD+6.95%
9.92 MUSD+287.19%
2.56 MUSD+121.92%
1.15 MUSD-74.69%
4.56 MUSD-52.33%
9.57 MUSD+668.52%
1.24 MUSD-25.26%
1.67 MUSD+537.64%
261,175.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Scisparc Stock analysis

What does Scisparc do? Scisparc Ltd., listed under the ticker SPRC with ISIN IL0010951403, is a biotechnology company headquartered in Tel Aviv-Yafo, Israel. The company operates in the healthcare sector and has a workforce of three employees. Scisparc Ltd. went public through an IPO on December 22, 2021. Its website is https://scisparc.com/. The company is engaged in the development of pharmaceutical products based on cannabinoid technologies, focusing on repurposing dronabinol for various medical conditions. Specific drug development programs include THX-110 for Tourette syndrome, Obstructive Sleep Apnea, and pain; THX-130 for Mild Cognitive Impairment and Traumatic Brain Injury; THX-150 for infectious diseases; and THX-160 for pain treatment. Scisparc Ltd. is a clinical stage pharmaceutical company, indicating its focus on advancing drug candidates through clinical trials toward potential regulatory approval and commercialization. The company's activities are centered around leveraging cannabinoid-based approaches to address unmet medical needs in multiple therapeutic areas. Scisparc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Scisparc stock

Total Assets of Scisparc is 7.62 M USD in 2025.

Total Assets of Scisparc changed from 10.35 M USD to 7.62 M USD, representing a -26.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets Scisparc since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's Scisparc historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Scisparc

All Key Metrics — Scisparc